ERBITUX 5 (Cetuximab)

ERBITUX 5 (Cetuximab) belongs to a class of drugs known as monoclonal antibodies. An “anti-neoplastic”, it works by blocking the function of a protein called the epidermal growth factor receptor (EGFR) that is found on the surface of many cancer cells as well as normal cells.

It is indicated for

• care for patients with RAS wild-type metastatic colorectal cancer (CRC)
• Squamous Cell Cancer of the Head and Neck
• Non-small Cell Lung Cancer
• Squamous Cell Skin Cancer

Available in Strengths of 20ml & 100ml